Profile
ABOS NVO VRTX REGN MRNA SGEN
Company Name Acumen Pharmaceuticals, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $201.87M $564.36B $109.10B $105.53B $44.96B $43.15B
Employees 0.05K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. Daniel J. O'Connell M.B.A. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
ABOS NVO VRTX REGN MRNA SGEN
Quant Rating Score 2 5 5 5 2 3
Quant Rating Sell Strong Buy Strong Buy Strong Buy Sell Neutral
Trading
ABOS NVO VRTX REGN MRNA SGEN
Last Close $3.36 $128.42 $422.78 $973.8 $117.31 $228.74
High 52 $9.72 $199.54 $446.08 $993.35 $137.75 $228.9
Low 52 $1.86 $87.78 $323.57 $692.45 $69.51 $187.64
Price vs. 52 Week High -65.43 % -35.64 % -5.22 % -1.97 % -14.84 % -0.07 %
Price vs. 52 Week Low 80.65 % 46.3 % 30.66 % 40.63 % 68.77 % 21.9 %
Total Return
ABOS NVO VRTX REGN MRNA SGEN
1 Month Return -10.16 % 3.14 % 6.61 % 7.64 % 11.58 % 0 %
3 Month Return 8.74 % 7.03 % 1.62 % 3.54 % 37.41 % 0 %
6 Month Return 65.52 % 27.43 % 11.58 % 22.23 % 67.08 % 7.29 %
9 Month Return -52.94 % -29.28 % 20.84 % 20.68 % 15.59 % 17.5 %
YTD Return -12.5 % 24.14 % 3.91 % 10.87 % 17.96 % 0 %
1 Year Return -40 % -25.02 % 21.69 % 30.83 % -9.27 % 14.94 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABOS NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -2050.67 % 1.1 % 8.49 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ABOS NVO VRTX REGN MRNA SGEN
Asset Growth 57.75 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth -8.88 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth - 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year -100 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year -100 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year -100 % 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth -35.15 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -29.39 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share -490.65 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share -450.23 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -450.23 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth -35.15 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) -22.5 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG -377.47 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG -421.73 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG -421.73 % 150.92 % 5187.08 % 713.56 % -4698.89 % -2622.09 %
EPS Growth -8 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth -8 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share 18.13 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 1286.18 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share 2031.02 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 2031.02 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 29468.57 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth -22.01 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ABOS NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM - 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -16.3 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -22.58 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -20.57 % 82.5 % 20.67 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 96.51 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 85.66 % 101.7 % 114.62 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM - 45.03 % 40.85 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -139.99 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM - 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 0.13 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM 1877.55 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM - 248.64 % 685.31 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM - 81.71 % 42.57 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -0.74 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -0.74 11.28 13.48 36.87 -9.61 -3.73
Cash Per Share TTM 420.51 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM - 38.24 % 38.74 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.05 % 53.85 % 88.22 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -139.99 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -4.69 77.59 31.36 26.55 -12.24 -61.54
Price To Operating Cash Flows Ratio TTM -4.52 42.4 27.68 22.15 -15.55 -79.67
Price Cash Flow Ratio TTM -4.52 42.4 27.68 22.15 -15.55 -79.67
Income Statement (TTM)
ABOS NVO VRTX REGN MRNA SGEN
Revenue $0B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $-0B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.06B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.05B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -1.08 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ABOS NVO VRTX REGN MRNA SGEN
Long Term Debt $0.03B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.04B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.27B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0.24B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.03B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.31B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ABOS NVO VRTX REGN MRNA SGEN
Net Income $-0.05B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.78
ABCL AbCellera Biologics Inc. 3.83
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.2
ABIO ARCA biopharma, Inc. 3.47
ABSI Absci Corporation 4.91
ABUS Arbutus Biopharma Corporation 2.88
ABVC ABVC BioPharma, Inc. 1.06
ABVX Abivax SA American Depositary Shares 14.09
ACAD ACADIA Pharmaceuticals Inc. 15.25
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.47
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9401
ACHV Achieve Life Sciences, Inc. 4.61
ACIU AC Immune SA 2.31
ACLX Arcellx, Inc. 49.74
ACRV Acrivon Therapeutics, Inc. Common Stock 8.77
ACST Acasti Pharma Inc. 2.76
ACXP Acurx Pharmaceuticals, Inc. 2.03
ETFs With Exposure to ABOS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 258.05
IBB iShares Biotechnology ETF 0.01258 133.4
BIB ProShares Ultra Nasdaq Biotechnology 0.00535472 54.47
VXF Vanguard Extended Market Index Fund 0 170.59
IWC iShares Micro-Cap ETF 0.03259 117.129
CSML IQ Chaikin U.S. Small Cap ETF 0.17 34.9484
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 89.47
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 89.45
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 46.27
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 46.27
VBINX Vanguard Balanced Index Fund Investor Shares 0 46.27
BMED BlackRock Future Health ETF 0.03 25.0141
DFAU Dimensional US Core Equity Market ETF 0.00048189 36.29
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 21.69
DFAS Dimensional U.S. Small Cap ETF 0.00026443 61.34
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002324 31.62
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03546 5.828
VTSAX Vanguard Total Stock Market Index Fund 0 125.62
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01585 6.2875
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 129.48
VITSX Vanguard Total Stock Market Index Fund 0 125.64
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01585 6.308
IBRN iShares Neuroscience and Healthcare ETF 0.28547 23.2733
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000172126 88.42
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129.49
DCOR Dimensional ETF Trust 0.00005219 58.1585
VEMPX Vanguard Extended Market Index InstlPlus 0 319.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 235.66
Unlock